Sep 2021 News Discover the magic of the 73037-81-7

If you’re interested in learning more about , below is a message from the blog Manager. 73037-81-7

73037-81-7, New Advances in Chemical Research, May 2021. Chemistry is the experimental science by definition. We want to make observations to prove hypothesis. For this purpose, we perform experiments in the lab. 73037-81-7, Name is 6-Chloro-4-methyl-1,2,3,4-tetrahydroisoquinoline,introducing its new discovery.

Light-enabled enantiodivergence is demonstrated in which the alkene substrate configuration is manipulated (E ? Z) prior to organocatalytic reduction with a chiral thiourea and Hantzsch ester. This allows stereodivergent reduction to be regulated at the substrate level with high fidelity and mitigates the need for a second, enantiomeric catalyst (up to 93:07 and 95:5 er). The synthetic utility of this strategy has been demonstrated in the synthesis of the weight-loss drug (R)-Lorcaserin (Belviq) and a potent AMPA modulator.

If you’re interested in learning more about , below is a message from the blog Manager. 73037-81-7

Reference:
Tetrahydroisoquinoline – Wikipedia,
1,2,3,4-Tetrahydroisoquinoline | C9H11N – PubChem

Brief introduction of 73037-81-7

If you¡¯re interested in learning more about 4602-73-7, below is a message from the blog Manager. 73037-81-7

Let¡¯s face it, organic chemistry can seem difficult to learn. Especially from a beginner¡¯s point of view. Like 73037-81-7, Name is 6-Chloro-4-methyl-1,2,3,4-tetrahydroisoquinoline. In a document type is Article, introducing its new discovery., 73037-81-7

Light-Enabled Enantiodivergence: Stereospecific Reduction of Activated Alkenes Using a Single Organocatalyst Enantiomer

Light-enabled enantiodivergence is demonstrated in which the alkene substrate configuration is manipulated (E ? Z) prior to organocatalytic reduction with a chiral thiourea and Hantzsch ester. This allows stereodivergent reduction to be regulated at the substrate level with high fidelity and mitigates the need for a second, enantiomeric catalyst (up to 93:07 and 95:5 er). The synthetic utility of this strategy has been demonstrated in the synthesis of the weight-loss drug (R)-Lorcaserin (Belviq) and a potent AMPA modulator.

If you¡¯re interested in learning more about 4602-73-7, below is a message from the blog Manager. 73037-81-7

Reference£º
Tetrahydroisoquinoline – Wikipedia,
1,2,3,4-Tetrahydroisoquinoline | C9H11N – PubChem